Lifecore Biomedical, Inc. LFCR Ratios & Valuation
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 3.8×+0.9× | 3.5×+0.8× | 2.8×+0.5× | —— | 2.8×+0.8× | |
| Quick ratio | 2.4×+0.6× | 2.3×+0.7× | 1.7×+0.5× | —— | 1.8×+0.7× | |
| Cash ratio | 1×+0.7× | 0.7×+0.6× | 0.6×+0.4× | —— | 0.3×+0.1× | |
| Leverage | ||||||
| Debt-to-assets | 0.7×+0.6× | 0.6×0.0× | 0×-0.4× | —— | 0×-0.4× | |
| Per Share | ||||||
| Book value per share | -$0.76-2,076% | —— | -$0.28-163% | —— | $0.04-87.6% | |
| Valuation | ||||||
| Market capitalization | $196.92M-35.4% | $269.76M+24.8% | $295.98M+29.5% | $284.67M+113% | $259.18M+46.4% | |
| Enterprise value | $333.06M+8.3% | $395.48M+13.6% | $285.57M-13.6% | —— | $262.04M-6.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Lifecore Biomedical, Inc.'s profit margins?
- Lifecore Biomedical, Inc. (LFCR) runs a 31.3% gross margin and a -14.5% operating margin, with a -30.0% net margin.
- Where do Lifecore Biomedical, Inc.'s ratios come from?
- Every ratio is computed from Lifecore Biomedical, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
